CVRX Quote, Financials, Valuation and Earnings

NeuroOne Medical Technologies Corp. has a net margin of -87.61% compared to CVRx, Inc.'s net margin of -59.08%. CVRx, Inc.'s return on equity of -83.48% beat NeuroOne Medical Technologies Corp.'s return on equity of -89.54%.

CVRx, Inc. has a consensus price target of $11.50, signalling upside risk potential of 41.8%. On the other hand NeuroOne Medical Technologies Corp. has an analysts' consensus of $2.30 which suggests that it could grow by 162.56%. Given that NeuroOne Medical Technologies Corp. has higher upside potential than CVRx, Inc., analysts believe NeuroOne Medical Technologies Corp. is more attractive than CVRx, Inc..

CVRx, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NeuroOne Medical Technologies Corp. has a beta of 0.575, suggesting its less volatile than the S&P 500 by 42.534%.

CVRx, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CVRx, Inc. pays -- of its earnings as a dividend. NeuroOne Medical Technologies Corp. pays out -- of its earnings as a dividend.

CVRx, Inc. quarterly revenues are $14.7M, which are larger than NeuroOne Medical Technologies Corp. quarterly revenues of $2.7M. CVRx, Inc.'s net income of -$12.9M is lower than NeuroOne Medical Technologies Corp.'s net income of -$1.6M. Notably, CVRx, Inc.'s price-to-earnings ratio is -- while NeuroOne Medical Technologies Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CVRx, Inc. is 3.73x versus 2.91x for NeuroOne Medical Technologies Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Nutriband, Inc. has a net margin of -87.61% compared to CVRx, Inc.'s net margin of -1118.87%. CVRx, Inc.'s return on equity of -83.48% beat Nutriband, Inc.'s return on equity of -164.64%.

CVRx, Inc. has a consensus price target of $11.50, signalling upside risk potential of 41.8%. On the other hand Nutriband, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 243.25%. Given that Nutriband, Inc. has higher upside potential than CVRx, Inc., analysts believe Nutriband, Inc. is more attractive than CVRx, Inc..

CVRx, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Nutriband, Inc. has a beta of 1.840, suggesting its more volatile than the S&P 500 by 84.015%.

CVRx, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CVRx, Inc. pays -- of its earnings as a dividend. Nutriband, Inc. pays out -- of its earnings as a dividend.

CVRx, Inc. quarterly revenues are $14.7M, which are larger than Nutriband, Inc. quarterly revenues of $346.1K. CVRx, Inc.'s net income of -$12.9M is lower than Nutriband, Inc.'s net income of -$3.9M. Notably, CVRx, Inc.'s price-to-earnings ratio is -- while Nutriband, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CVRx, Inc. is 3.73x versus 21.81x for Nutriband, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

enVVeno Medical Corp. has a net margin of -87.61% compared to CVRx, Inc.'s net margin of --. CVRx, Inc.'s return on equity of -83.48% beat enVVeno Medical Corp.'s return on equity of -57.7%.

CVRx, Inc. has a consensus price target of $11.50, signalling upside risk potential of 41.8%. On the other hand enVVeno Medical Corp. has an analysts' consensus of $12.50 which suggests that it could grow by 3372.22%. Given that enVVeno Medical Corp. has higher upside potential than CVRx, Inc., analysts believe enVVeno Medical Corp. is more attractive than CVRx, Inc..

CVRx, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison enVVeno Medical Corp. has a beta of 1.040, suggesting its more volatile than the S&P 500 by 4.044%.

CVRx, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. enVVeno Medical Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CVRx, Inc. pays -- of its earnings as a dividend. enVVeno Medical Corp. pays out -- of its earnings as a dividend.

CVRx, Inc. quarterly revenues are $14.7M, which are larger than enVVeno Medical Corp. quarterly revenues of --. CVRx, Inc.'s net income of -$12.9M is lower than enVVeno Medical Corp.'s net income of -$4.5M. Notably, CVRx, Inc.'s price-to-earnings ratio is -- while enVVeno Medical Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CVRx, Inc. is 3.73x versus 473.07x for enVVeno Medical Corp.. Usually stocks with elevated PS ratios are considered overvalued.

SINTX Technologies, Inc. has a net margin of -87.61% compared to CVRx, Inc.'s net margin of -1701.44%. CVRx, Inc.'s return on equity of -83.48% beat SINTX Technologies, Inc.'s return on equity of -208.36%.

CVRx, Inc. has a consensus price target of $11.50, signalling upside risk potential of 41.8%. On the other hand SINTX Technologies, Inc. has an analysts' consensus of $12.25 which suggests that it could grow by 224.07%. Given that SINTX Technologies, Inc. has higher upside potential than CVRx, Inc., analysts believe SINTX Technologies, Inc. is more attractive than CVRx, Inc..

CVRx, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison SINTX Technologies, Inc. has a beta of 0.649, suggesting its less volatile than the S&P 500 by 35.053%.

CVRx, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SINTX Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CVRx, Inc. pays -- of its earnings as a dividend. SINTX Technologies, Inc. pays out -- of its earnings as a dividend.

CVRx, Inc. quarterly revenues are $14.7M, which are larger than SINTX Technologies, Inc. quarterly revenues of $208K. CVRx, Inc.'s net income of -$12.9M is lower than SINTX Technologies, Inc.'s net income of -$3.5M. Notably, CVRx, Inc.'s price-to-earnings ratio is -- while SINTX Technologies, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CVRx, Inc. is 3.73x versus 6.41x for SINTX Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.